StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories post-Retirement Medical & Dental Plans — Benefit Obligation ($M) ($M)

Form 10-K Post-Employment Benefits Footnote

Latest, Q4 2025
1,386
Period ended Dec 31, 2025
Change on a year earlier
+18.9%
1,166 in Q4 2024
History
11 quarters
Since Q4 2015
Sources
9
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPost-Retirement Medical & Dental Plans — Benefit Obligation ($M) ($M)Year on yearSource
Q4 2025Dec 31, 20251,386+18.9%SEC Filing (0001628280-26-010185) ↗
Q4 2024Dec 31, 20241,166-1.3%SEC Filing (0001628280-26-010185) ↗
Q4 2023Dec 31, 20231,181+4.9%SEC Filing (0001628280-26-010185) ↗
Q4 2022Dec 31, 20221,126-28.1%SEC Filing (0001628280-25-007110) ↗
Q4 2021Dec 31, 20211,566-0.1%SEC Filing (0001628280-24-005348) ↗
Q4 2020Dec 31, 20201,567+0.7%SEC Filing (0001628280-23-004026) ↗
Q4 2019Dec 31, 20191,556+20.4%SEC Filing (0001104659-22-025141) ↗
Q4 2018Dec 31, 20181,292-7.3%SEC Filing (0001104659-21-025751) ↗
Q4 2017Dec 31, 20171,393+9.3%SEC Filing (0001104659-20-023904) ↗
Q4 2016Dec 31, 20161,274+1.0%SEC Filing (0001047469-19-000624) ↗
Q4 2015Dec 31, 20151,262–SEC Filing (0001047469-18-000856) ↗

Cite this data

StockData. (2026). Abbott Laboratories Post-Retirement Medical & Dental Plans — Benefit Obligation ($M) ($M), quarterly Q4 2015–Q4 2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/xbrl-postret-pbo

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.